Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-109311
Filing Date
2024-12-16
Accepted
2024-12-16 16:15:39
Documents
74
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0224507-10q_enzobio.htm   iXBRL 10-Q 534752
2 CERTIFICATION ea022450701ex31-1_enzobio.htm EX-31.1 9648
3 CERTIFICATION ea022450701ex31-2_enzobio.htm EX-31.2 9645
4 CERTIFICATION ea022450701ex32-1_enzobio.htm EX-32.1 3348
5 CERTIFICATION ea022450701ex32-2_enzobio.htm EX-32.2 2899
  Complete submission text file 0001213900-24-109311.txt   4565159

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20241031.xsd EX-101.SCH 39556
7 XBRL CALCULATION FILE enz-20241031_cal.xml EX-101.CAL 54148
8 XBRL DEFINITION FILE enz-20241031_def.xml EX-101.DEF 220261
9 XBRL LABEL FILE enz-20241031_lab.xml EX-101.LAB 415017
10 XBRL PRESENTATION FILE enz-20241031_pre.xml EX-101.PRE 232147
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0224507-10q_enzobio_htm.xml XML 473618
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 241551998
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)